Overview
Announcements

Ordinary Adjustment | Solactive China Healthcare Disruption Index | Effective 01. September 2021

Solactive China Healthcare Disruption Index:

In the ordinary rebalancing effective open September 01, 2021 the following index composition was implemented:

3SBIO INC 0.8817 %
AKESO INC 1.3103 %
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD 6.8662 %
ALPHAMAB ONCOLOGY 0.7466 %
ANGELALIGN TECHNOLOGY INC 2.592 %
BEIGENE LTD 8.8656 %
BRII BIOSCIENCES LTD 1.0368 %
CANSINO BIOLOGICS INC 5.1266 %
CARSGEN THERAPEUTICS HOLDING 0.8996 %
CHINA MEDICAL SYSTEM HOLDINGS LTD 1.5021 %
EVEREST MEDICINES LTD 0.5701 %
GENSCRIPT BIOTECH CORP 3.0912 %
HANSOH PHARMACEUTICAL GROUP CO 5.0203 %
INNOCARE PHARMA LTD 1.3012 %
INNOVENT BIOLOGICS INC 3.6481 %
JD HEALTH INTERNATIONAL INC 8.1423 %
JOINN LABORATORIES CHINA C-H 2.3447 %
KEYMED BIOSCIENCES INC 0.5686 %
KINTOR PHARMACEUTICAL LTD 1.206 %
LIFETECH SCIENTIFIC CORP 0.7756 %
MICROPORT CARDIOFLOW MEDTECH 0.7668 %
MICROPORT SCIENTIFIC CORP 3.4947 %
NEW HORIZON HEALTH LTD 0.8163 %
PEIJIA MEDICAL LTD 0.6077 %
PING AN HEALTHCARE AND TECHNOL 2.627 %
REMEGEN CO LTD-H 1.9638 %
SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD 2.3092 %
SHANGHAI JUNSHI BIOSCIENCES CO LTD 2.2154 %
SIMCERE PHARMACEUTICAL GROUP 0.8151 %
SINO BIOPHARMACEUTICAL LTD ORD 4.8951 %
VENUS MEDTECH HANGZHOU INC 0.662 %
WUXI APPTEC CO LTD 8.4707 %
WUXI BIOLOGICS CAYMAN INC 8.4432 %
YIDU TECH INC 1.2627 %
ZAI LAB LTD 4.1548 %